GPX3 methylation is associated with hematologic improvement in low-risk myelodysplastic syndrome patients treated with Pai-Neng-Da

OBJECTIVE: The aim of this prospective randomized controlled clinical trial was to explore the relationship between GPX3 methylation and Pai-Neng-Da (PND) in the treatment of patients with low-risk myelodysplastic syndrome (MDS). METHODS: There were 82 low-risk MDS patients who were randomly divided...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shujun, Gao, Tong, Zheng, Zhonghua, Lai, Binbin, Sheng, Lixia, Xu, Zhijuan, Yan, Xiao, Wang, Jiaping, Duan, Shiwei, Ouyang, Guifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Prospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520939/
https://www.ncbi.nlm.nih.gov/pubmed/32967500
http://dx.doi.org/10.1177/0300060520956894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520939/
https://www.ncbi.nlm.nih.gov/pubmed/32967500
http://dx.doi.org/10.1177/0300060520956894

Ejemplares similares